Dipal Doshi - Insider Trading & Ownership

Entity: Individual
Location: C/O Amicus Therapeutics, 1 Cedar Brook Drive, Cranbury, NJ
Summary: The estimated net worth of Dipal Doshi is at least $5.14M dollars as of February 11, 2025. Dipal Doshi is the CEO, Director of Entrada Therapeutics, Inc. and owns shares of Entrada Therapeutics, Inc. (TRDA) stock worth about $4.93M. Dipal Doshi is the Director of Azenta, Inc. and owns shares of Azenta, Inc. (AZTA) stock worth about $211K.
All Insider Reports: All Insider Reports

Ownership of Dipal Doshi

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
TRDA	Entrada Therapeutics, Inc.	CEO, Director	$4.93M	-$95.2K	-1.9%	Sep 3, 2024
AZTA	Azenta, Inc.	Director	$211K			Feb 7, 2025

Showing 1 to 2 of 2 entries

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
Loading...

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.